Successful treatment of EBV-related lymphoproliferative disease after heart transplantation with autologous hematopoietic stem cell transplantation despite transient heart failure associated with engraftment syndrome

Ann Hematol. 2021 Apr;100(4):1097-1100. doi: 10.1007/s00277-020-04198-w. Epub 2020 Aug 6.

Megumi Yasunaga¹, Yohei Yasuda¹, Akira Honda¹, Hiroaki Maki¹, Kazuhiro Toyama¹, Yosuke Masamoto¹, Chie Bujo², Eisuke Amiya^{2

3}, Masaru Hatano^{2

3}, Minoru Ono⁴, Issei Komuro², Mineo Kurokawa^{5

6}

¹ Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
² Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
³ Department of Therapeutic Strategy for Heart Failure, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
⁴ Department of Cardiac Surgery, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
⁵ Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan. [email protected].
⁶ Department of Cell Therapy and Transplantation Medicine, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan. [email protected].

No abstract available

Publication types